v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net loss $ (1,135,290) $ (1,196,898)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation and amortization 120,629 88,600
Non-cash interest expense, net 985 1,442
Stock-based compensation expense 448,636 499,246
Loss from equity method investments 2,479 549
(Gain) loss on remeasurement of warrant liabilities (20,199) 2,905
Gain on equity securities and other financial assets, net (32,483) 0
Deferred income taxes (78,051) (11,737)
Other expenses, net (5,109) 0
Change in operating assets and liabilities, net of effect of business combinations:    
Receivables reserved for users (34,691) 131
Accounts receivable 13,834 (421)
Prepaid expenses and other current assets (20,669) (19,093)
Deposits and other non-current assets (1,989) (4,760)
Operating leases, net 698 (1,212)
Accounts payable and accrued expenses 129,233 194,735
Other long-term liabilities 9,476 (856)
Long-term income tax liability (11,200) 7,789
Liabilities to users 136,650 192,319
Net cash flows used in operating activities (477,061) (247,261)
Investing Activities:    
Purchases of property and equipment (19,903) (11,171)
Cash paid for internally developed software costs (46,513) (31,242)
Acquisition of gaming licenses (3,919) (7,563)
Cash paid for acquisitions, net of cash acquired (96,507) (64,969)
Other investing activities (5,090) (3,750)
Net cash flows used in investing activities (171,932) (118,695)
Financing Activities:    
Proceeds from issuance of convertible notes, net 0 1,247,116
Purchase of capped call options 0 (123,970)
Proceeds from shares issued for warrants 44 199
Purchase of treasury stock (22,012) (14,334)
Proceeds from exercise of stock options 5,125 25,118
Net cash flows (used in) provided by financing activities (16,843) 1,134,129
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 0 1,884
Net (decrease) increase in cash and cash equivalents and restricted cash (665,836) 770,057
Cash and cash equivalents and restricted cash at the beginning of period 2,629,842 2,104,976
Cash and cash equivalents and restricted cash, end of period 1,964,006 2,875,033
Disclosure of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 1,382,651 2,394,865
Cash reserved for users 581,355 480,168
Total cash, cash equivalents and restricted cash, end of period 1,964,006 2,875,033
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Equity consideration issued for acquisitions 460,128 33,149
Acquisition of property and equipment, internally developed software and other investments included in accounts payable and accrued expenses 12,835 2,338
Convertible notes financing costs included in accounts payable and accrued expenses 0 773
Acquisition of gaming licenses included in accounts payable and accrued expenses 0 (4,976)
Increase of other current assets from transfer agent related to warrants 0 525
Supplemental Disclosure of Cash Activities:    
Increase in cash reserved for users 104,405 192,450
Cash paid for interest $ 0 $ 0